◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

Hemostemix Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Total Revenue 0.00 0.00 0.00 0.00 0.00 --
Operating Revenue 0.00 0.00 0.00 0.00 0.00 --
Selling General And Administration 1.3M 447,847 1.0M 969,345 261,985 --
General And Administrative Expense 1.2M 425,797 954,603 958,016 258,554 --
Research And Development 401,551 2,747 0.00 0.00 0.00 --
Depreciation And Amortization In Income Statement 11.00 12.00 12.00 25.00 25.00 --
Other Operating Expenses 66,482 31,256 31,870 45,825 11,659 --
Operating Expense 1.8M 481,862 1.0M 1.0M 273,669 --
Operating Income -1.8M -481,862 -1.0M -1.0M -273,669 --
EBIT -305,193 -134,800 -1.1M -1.1M -157,458 --
Interest Expense 192,562 172,852 166,177 162,711 157,101 --
Interest Expense Non Operating 192,562 172,852 166,177 162,711 157,101 --
Net Interest Income -193,394 -173,124 -166,177 -171,687 -157,387 --
Other Income Expense 1.5M 347,334 -82,997 -120,083 116,497 --
Other Non Operating Income Expenses 315,781 306,837 -- -- -- --
Special Income Charges 985,067 -- -- 0.00 0.00 0.00
Gain On Sale Of Security 153,082 40,497 -82,997 -120,083 116,497 --
Pretax Income -497,755 -307,652 -1.3M -1.3M -314,559 --
Tax Effect Of Unusual Items 0.00 0.00 0.00 0.00 0.00 --
Net Income From Continuing And Discontinued Operation -497,755 -307,652 -1.3M -1.3M -314,559 --
Net Income From Continuing Operation Net Minority Interest -497,755 -307,652 -1.3M -1.3M -314,559 --
Net Income Including Noncontrolling Interests -497,755 -307,652 -1.3M -1.3M -314,559 --
Net Income Common Stockholders -497,755 -307,652 -1.3M -1.3M -314,559 --
Net Income -497,755 -307,652 -1.3M -1.3M -314,559 --
EBITDA -305,182 -134,788 -1.1M -1.1M -157,433 --
Normalized EBITDA -1.4M -175,285 -1.0M -1.0M -273,930 --
Reconciled Depreciation 11.00 11.00 12.00 25.00 25.00 --
Basic EPS -0.00 -0.00 -0.01 -- -0.00 -0.01
Diluted EPS -0.00 -0.00 -0.01 -- -0.00 -0.01
Basic Average Shares 146.5M 146.5M 95.1M -- 87.1M 87.1M
Diluted Average Shares 146.5M 146.5M 95.1M -- 87.1M 87.1M
Total Unusual Items 1.1M 40,497 -82,997 -120,083 116,497 --
Total Unusual Items Excluding Goodwill 1.1M 40,497 -82,997 -120,083 116,497 --
Tax Rate For Calcs 0.00 0.00 0.00 0.00 0.00 --
Normalized Income -1.6M -348,149 -1.2M -1.2M -431,056 --
Depreciation Amortization Depletion Income Statement 11.00 12.00 12.00 25.00 25.00 --
Depreciation Income Statement 11.00 12.00 12.00 25.00 25.00 --
Diluted NI Availto Com Stockholders -497,755 -307,652 -1.3M -1.3M -314,559 --
Net Income Continuous Operations -497,755 -307,652 -1.3M -1.3M -314,559 --
Net Non Operating Interest Income Expense -193,394 -173,124 -166,177 -171,687 -157,387 --
Other Gand A 709,227 410,939 407,053 639,462 254,411 --
Other Special Charges -985,067 -- -- -- -- --
Salaries And Wages 476,844 14,858 547,550 318,554 4,143 --
Selling And Marketing Expense 104,176 22,050 48,893 11,329 3,431 --
Total Expenses 1.8M 481,862 1.0M 1.0M 273,669 --
Total Other Finance Cost 832.00 272.00 -- 8,976 286.00 338.00
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Cash And Cash Equivalents 1.2M 679,005 965,164 705,700 63,327 --
Cash Cash Equivalents And Short Term Investments 1.3M 824,585 965,164 705,700 63,327 --
Cash Financial 1.2M 679,005 965,164 705,700 63,327 --
Other Short Term Investments 145,580 145,580 -- -- -- --
Receivables 22,228 40,284 69,502 229,604 3,215 --
Prepaid Assets 14,325 61,737 48,066 56,475 91,658 --
Current Assets 1.3M 926,606 1.1M 991,779 158,200 --
Gross PPE 6,138 6,138 6,138 6,138 6,138 --
Accumulated Depreciation -6,089 -6,078 -6,067 -6,055 -6,030 --
Net PPE 49.00 60.00 71.00 83.00 108.00 --
Goodwill And Other Intangible Assets 1.00 1.00 1.00 1.00 1.00 --
Other Intangible Assets 1.00 1.00 1.00 1.00 -- --
Investments And Advances -- -- 145,580 -- -- --
Total Non Current Assets 50.00 61.00 145,652 84.00 109.00 --
Total Assets 1.3M 926,667 1.2M 991,863 158,309 --
Accounts Payable -- -- -- 2.8M -- --
Payables -- -- -- 2.8M -- --
Payables And Accrued Expenses 868,486 2.7M 3.5M 2.8M 3.6M --
Current Liabilities 868,486 2.7M 3.5M 2.8M 3.6M --
Long Term Debt 3.4M 4.9M 4.7M 4.9M 4.8M --
Long Term Debt And Capital Lease Obligation 3.4M 4.9M 4.7M 4.9M 4.8M --
Total Non Current Liabilities Net Minority Interest 3.9M 5.4M 5.2M 5.4M 5.3M --
Total Liabilities Net Minority Interest 4.8M 8.1M 8.7M 8.2M 8.8M --
Common Stock 47.5M 45.0M 44.4M 43.9M 42.5M --
Capital Stock 47.5M 45.0M 44.4M 43.9M 42.5M --
Additional Paid In Capital 14.2M 13.8M 13.8M 13.2M 12.9M --
Retained Earnings -67.6M -67.1M -67.0M -65.9M -64.6M --
Common Stock Equity -3.5M -7.2M -7.5M -7.2M -8.7M --
Stockholders Equity -3.5M -7.2M -7.5M -7.2M -8.7M --
Total Equity Gross Minority Interest -3.5M -7.2M -7.5M -7.2M -8.7M --
Total Capitalization -16,519 -2.3M -2.8M -2.3M -3.9M --
Net Tangible Assets -3.5M -7.2M -7.5M -7.2M -8.7M --
Tangible Book Value -3.5M -7.2M -7.5M -7.2M -8.7M --
Working Capital 470,352 -1.8M -2.4M -1.8M -3.4M --
Invested Capital -16,519 -2.3M -2.8M -2.3M -3.9M --
Total Debt 3.4M 4.9M 4.7M 4.9M 4.8M --
Net Debt 2.3M 4.2M 3.7M 4.2M 4.7M --
Share Issued 183.7M 147.5M 145.3M 140.6M 87.1M --
Ordinary Shares Number 183.7M 147.5M 145.3M 140.6M 87.1M --
Machinery Furniture Equipment 6,138 6,138 6,138 -- 6,138 6,138
Non Current Deferred Liabilities 486,921 486,921 486,921 486,921 486,921 --
Non Current Deferred Taxes Liabilities 486,921 486,921 486,921 486,921 486,921 --
Other Equity Interest 2.4M 1.2M 1.4M 1.5M 521,735 --
Other Properties -- -- -- 6,138 -- --
Other Receivables -- 15,760 -- 200,000 -- --
Taxes Receivable 22,228 24,524 69,502 29,604 3,215 --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Operating Cash Flow -2.9M -801,212 337,466 -1.8M -40,425 --
Cash Flow From Continuing Operating Activities -2.9M -801,212 337,466 -1.8M -40,425 --
Depreciation And Amortization 11.00 11.00 12.00 25.00 25.00 --
Depreciation Amortization Depletion 11.00 11.00 12.00 25.00 25.00 --
Stock Based Compensation 476,844 14,858 547,550 318,554 4,143 --
Change In Working Capital -2.0M -760,172 909,489 -984,448 112,864 --
Change In Receivables 18,056 29,218 160,102 -226,389 17,512 --
Change In Payables And Accrued Expense -2.1M -775,719 740,978 -793,242 67,846 --
Other Non Cash Items 192,560 172,853 164,967 162,711 157,102 --
Purchase Of Investment 0.00 0.00 -145,580 -- 0.00 0.00
Net Investment Purchase And Sale 0.00 0.00 -145,580 -- 0.00 0.00
Investing Cash Flow 0.00 0.00 -145,580 -- 0.00 0.00
Cash Flow From Continuing Investing Activities 0.00 0.00 -145,580 -- 0.00 0.00
Issuance Of Capital Stock 3.4M -- -- 2.5M 0.00 --
Net Common Stock Issuance 3.4M -- -- 2.5M 0.00 --
Financing Cash Flow 3.4M 515,053 67,578 2.5M 0.00 --
Cash Flow From Continuing Financing Activities 3.4M 515,053 67,578 2.5M 0.00 --
Changes In Cash 477,700 -286,159 259,464 642,373 -40,425 --
Beginning Cash Position 679,005 965,164 705,700 63,327 103,752 --
End Cash Position 1.2M 679,005 965,164 705,700 63,327 --
Free Cash Flow -2.9M -801,212 337,466 -1.8M -40,425 --
Change In Prepaid Assets 47,412 -13,671 8,409 35,183 27,506 --
Common Stock Issuance 3.4M -- -- 2.5M 0.00 --
Depreciation 11.00 11.00 12.00 25.00 25.00 --
Net Foreign Currency Exchange Gain Loss -- -- 0.00 0.00 -- --
Net Income From Continuing Operations -578,751 -228,762 -1.3M -1.3M -314,559 --
Proceeds From Stock Option Exercised 13,680 32,886 67,578 0.00 0.00 --
NEWS
Loading news...
TRENDING
Loading...